Publication | Open Access
A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine
14
Citations
13
References
2020
Year
(<sup>34</sup> Pro,<sup>35</sup> Phe)CGRP<sub>27-37</sub> is a potent CGRP receptor antagonist both in vitro and in vivo, and it can be formulated as a dry powder with no loss of activity indicating its potential as a nasally formulated anti-migraine medicine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1